Display options
Share it on

J Palliat Care Med. 2012;2(6). doi: 10.4172/2165-7386.1000125. Epub 2012 Aug 08.

A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy.

Journal of palliative care & medicine

Joshua Bauml, Sharon X Xie, Courtney Penn, Krupali Desai, Kimberly W Dong, Deborah Watkins Bruner, Neha Vapiwala, Jun James Mao

Affiliations

  1. Abramson Cancer Center, University of Pennsylvania, 3400 Spruce Street/2 Gates, Philadelphia, Pennsylvania 19104, USA.
  2. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 3400 Spruce Street/2 Gates, Philadelphia, Pennsylvania 19104, USA.
  3. Department of Family Medicine and Community Health, University of Pennsylvania, 3400 Spruce Street/2 Gates, Philadelphia, Pennsylvania 19104, USA.
  4. Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street/2 Gates, Philadelphia, Pennsylvania 19104, USA.
  5. Woodruff School of Nursing, University of Emory, Georgia 30322, USA.

PMID: 29479490 PMCID: PMC5824725 DOI: 10.4172/2165-7386.1000125

Abstract

PURPOSE: Cancer-Related Fatigue (CRF) negatively affects quality of life among cancer patients. This study seeks to evaluate the outcome and patient receptiveness of a brief counseling program based on National Cancer Institute (NCI) PDQ® information to manage CRF when integrated into Radiation Therapy (RT).

METHODS: We conducted a prospective cohort study among patients undergoing non-palliative RT. Patients with stage I-III tumors and with Karnofsky score 60 or better were given a ten-minute behavioral counseling session during the first two weeks of RT. The Brief Fatigue Inventory (BFI) was administered at baseline/end of RT.

RESULTS: Of 93 patients enrolled, 89% found the counseling useful and practical. By the end of RT, 59% reported increased exercise, 41.6% sought nutrition counseling, 72.7% prioritized daily activities, 74.4% took daytime naps, and 70.5% talked with other cancer patients. Regarding counseling, patients who had received chemotherapy prior to RT had no change in fatigue (-0.2), those who received RT alone had mild increase in fatigue (0.7, p=0.02), and those who received concurrent chemotherapy experienced a substantial increase in fatigue (3.0 to 5.2, p=0.05). Higher baseline fatigue and receipt of chemotherapy were predictive of worsened fatigue in a multivariate model (both p<0.01).

CONCLUSION: Our data suggests that brief behavioral counseling based on NCI guidelines is well accepted by patients showing an uptake in many activities to cope with CRF. Those who receive concurrent chemotherapy and with higher baseline fatigue are at risk for worsening fatigue despite of guideline-based therapy.

Keywords: Adverse effects; Cohort study; Counseling; Fatigue; Neoplasms; Radiotherapy

References

  1. Cancer. 2004 Aug 1;101(3):550-7 - PubMed
  2. J Pain Symptom Manage. 2006 Jun;31(6):542-52 - PubMed
  3. Strahlenther Onkol. 2010 Jan;186(1):46-52 - PubMed
  4. J Palliat Care. 1991 Summer;7(2):25-9 - PubMed
  5. J Clin Oncol. 2006 Oct 20;24(30):4882-7 - PubMed
  6. Cancer Invest. 2000;18(1):11-9 - PubMed
  7. Semin Hematol. 2000 Oct;37(4 Suppl 6):14-7 - PubMed
  8. Cancer. 2000 Oct 1;89(7):1634-46 - PubMed
  9. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33 - PubMed
  10. Semin Oncol Nurs. 2001 Nov;17(4):249-54 - PubMed
  11. J Clin Oncol. 2011 Sep 10;29(26):3517-22 - PubMed
  12. J Natl Compr Canc Netw. 2007 Nov;5(10):1054-78 - PubMed
  13. Semin Oncol Nurs. 2006 Feb;22(1):31-5 - PubMed
  14. Cancer. 2005 Oct 15;104(8):1772-8 - PubMed
  15. Clin Cancer Res. 2006 May 1;12(9):2759-66 - PubMed
  16. Clin Cancer Res. 2009 Sep 1;15(17):5534-40 - PubMed
  17. Eur J Cancer. 2004 Mar;40(5):673-80 - PubMed
  18. Cancer. 1999 Mar 1;85(5):1186-96 - PubMed
  19. Curr Oncol Rep. 2005 Jul;7(4):277-82 - PubMed
  20. Breast Cancer Res Treat. 2007 Oct;105(2):209-19 - PubMed
  21. Crit Rev Oncol Hematol. 2002 Mar;41(3):317-25 - PubMed
  22. Eur J Cancer. 2002 Jan;38(1):27-43 - PubMed
  23. Br J Cancer. 2007 Sep 3;97(5):612-8 - PubMed
  24. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006145 - PubMed
  25. Cancer. 1997 Oct 15;80(8):1518-24 - PubMed
  26. Psychoneuroendocrinology. 2009 Nov;34(10):1476-85 - PubMed
  27. Phys Med Rehabil Clin N Am. 2009 May;20(2):405-16 - PubMed
  28. Qual Life Res. 1994 Jun;3(3):183-9 - PubMed
  29. J Cancer Res Ther. 2010 Jan-Mar;6(1):22-6 - PubMed
  30. Cancer. 2001 Sep 15;92(6 Suppl):1725-32 - PubMed
  31. Soc Sci Med. 1991;32(9):981-7 - PubMed
  32. Oncol Nurs Forum. 1994 Jan-Feb;21(1):23-36 - PubMed
  33. Cancer Nurs. 2002 Aug;25(4):283-97; quiz 298-9 - PubMed
  34. Oncol Nurs Forum. 1998 Jun;25(5):915-20 - PubMed
  35. Cancer. 2004 Mar 15;100(6):1302-10 - PubMed
  36. J Pain Symptom Manage. 2009 Nov;38(5):650-62 - PubMed
  37. Cancer. 2006 Feb 15;106(4):751-8 - PubMed
  38. Evid Based Complement Alternat Med. 2011;2011:null - PubMed
  39. J Pain Symptom Manage. 2004 Oct;28(4):373-80 - PubMed
  40. J Altern Complement Med. 2011 Jun;17(6):505-12 - PubMed
  41. Biol Psychiatry. 2005 Feb 1;57(3):239-46 - PubMed
  42. J Pain Symptom Manage. 2011 Apr;41(4):761-7 - PubMed
  43. J Clin Oncol. 2000 Feb;18(4):743-53 - PubMed
  44. Soc Sci Med. 1999 Jun;48(11):1531-48 - PubMed
  45. J Clin Oncol. 2008 Feb 20;26(6):971-82 - PubMed
  46. Oncol Nurs Forum. 1998 Apr;25(3):485-91 - PubMed
  47. Cancer Nurs. 2010 May-Jun;33(3):201-12 - PubMed
  48. J Clin Oncol. 2005 Nov 20;23(33):8280-2 - PubMed
  49. Cancer. 2007 Sep 15;110(6):1385-95 - PubMed
  50. Oncologist. 2007;12 Suppl 1:22-34 - PubMed
  51. Eur J Cancer. 2003 Mar;39(5):587-94 - PubMed
  52. Eur J Cancer. 2003 Jul;39(11):1562-7 - PubMed
  53. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006953 - PubMed

Publication Types

Grant support